- Home
- FIZZ vs LNTH Comparison
FIZZ vs LNTH Comparison
Compare FIZZ & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FIZZ
- LNTH
- Stock Information
- Founded
- FIZZ 1985
- LNTH 1956
- Country
- FIZZ United States
- LNTH United States
- Employees
- FIZZ N/A
- LNTH N/A
- Industry
- FIZZ Beverages (Production/Distribution)
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- FIZZ Consumer Staples
- LNTH Health Care
- Exchange
- FIZZ Nasdaq
- LNTH Nasdaq
- Market Cap
- FIZZ 3.1B
- LNTH 3.8B
- IPO Year
- FIZZ 1991
- LNTH 2015
- Fundamental
- Price
- FIZZ $33.49
- LNTH $53.42
- Analyst Decision
- FIZZ Strong Sell
- LNTH Buy
- Analyst Count
- FIZZ 1
- LNTH 6
- Target Price
- FIZZ $39.00
- LNTH $74.17
- AVG Volume (30 Days)
- FIZZ 347.5K
- LNTH 1.3M
- Earning Date
- FIZZ 12-04-2025
- LNTH 11-06-2025
- Dividend Yield
- FIZZ N/A
- LNTH N/A
- EPS Growth
- FIZZ 0.66
- LNTH N/A
- EPS
- FIZZ 1.98
- LNTH 2.39
- Revenue
- FIZZ $1,202,396,000.00
- LNTH $1,525,933,000.00
- Revenue This Year
- FIZZ $2.80
- LNTH N/A
- Revenue Next Year
- FIZZ $2.19
- LNTH $1.98
- P/E Ratio
- FIZZ $16.44
- LNTH $22.36
- Revenue Growth
- FIZZ 0.46
- LNTH 1.95
- 52 Week Low
- FIZZ $32.21
- LNTH $47.25
- 52 Week High
- FIZZ $50.51
- LNTH $111.29
- Technical
- Relative Strength Index (RSI)
- FIZZ 44.40
- LNTH 46.61
- Support Level
- FIZZ $32.32
- LNTH $51.47
- Resistance Level
- FIZZ $33.83
- LNTH $55.55
- Average True Range (ATR)
- FIZZ 0.93
- LNTH 2.67
- MACD
- FIZZ 0.16
- LNTH -0.30
- Stochastic Oscillator
- FIZZ 60.91
- LNTH 28.53
About FIZZ National Beverage Corp.
National Beverage Corp is a non-alcoholic beverage company in the U.S. Its portfolio skews toward functional drinks (that is those purporting to offer health benefits) and is anchored by the popular LaCroix sparkling water trademark. Other offerings include Rip It energy drinks, Everfresh juices, and soda brands like Shasta and Faygo. The firm controls the majority of its production and distribution apparatus, with very little outsourcing. In terms of go-to-market, it uses warehouse distribution for retailers, direct-store delivery for convenience stores and other small outlets, and food-service distributors for the food-service channel (schools, hospitals, restaurants).
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.